The main aim of the campaign is to persuade anyone thinking of getting a puppy that they should always see the animal at least once whilst it is still dependent on its mother, before they buy. That way, they'll be able to reassure themselves that they have seen the real bitch and the environment in which the puppy was bred. It will also help prevent impulse purchases.
In addition, the campaign aims to raise awareness in the veterinary profession, so that veterinary surgeons are giving this same advice to their clients.
To that end, the campaign highlights the RSPCA 'Sold a pup' report which showed that over 400,000 pups are bred for the UK market each year by unlicensed establishments, and imports from Europe have increased to an estimated 30,000 in 2015, following the change in the PETS scheme in 2012.
The campaigners say that many of these puppies are bred in truly awful conditions, often with little or no human contact, before being taken taken from their mothers too early and transported often hundreds or thousands of miles to be sold as 'family' pets. Many will need veterinary care to deal with infections, inherited issues and behavioural problems.
The campaign faces a big challenge. In the Kennel Club PAW survey 2014, 41% of people who bought a puppy didn't see the bitch and 51% didn't see the environment where the litter was bred.
To spread the word, veterinary surgeons, veterinary nurses and pet owners are being asked to take a pouting selfie with their dog and post it on social networks like Facebook, with the hashtags #PoutForPuppies #SeeThemSuckling, linking to the campaign website: https://seethemsuckling.com
The webinars each last between three and five minutes and are part of the 2016 ‘Talk About Laminitis’ disease awareness initiative to help detect, manage and monitor PPID.
The webinars can be viewed on the Boehringer Academy website – www.boehringer-academy.co.uk - and podcast versions are also available enabling veterinary professionals to listen to them ‘on the go’.
The first series includes:
The second webinar series covers:
For further information on the webinars or podcasts visit www.boehringer-academy.co.uk or contact your local Boehringer Ingelheim territory manager.
The campaign – Cats deserve pain relief too – has been prompted by a recent study1 which revealed that perioperative analgesia following neutering was only given to 33% of cats compared with 75% of dogs, a statistic which ISFM says it is very keen to change.
The campaign, which includes a free webinar for veterinary professionals, highlights the reasons many cats are not receiving postoperative analgesia, and aims to encourage practices to review their policies on prescribing analgesics for routine neutering procedures.
ISFM says it already encourages the routine assessment and treatment of pain in cats. However, recognition of pain is not always straightforward and the perception that cats experience less pain than dogs with neutering may largely reflect different behavioural responses to pain between the two species rather than genuine differences in the experience of pain.
The charity says that physiologically, it makes sense that both species are likely to feel pain for several days after a surgical procedure and studies have shown that cats do show behavioural changes indicative of pain for 3 days or more after neutering.2 However we also know that cats are less demonstrative and less likely to show overt signs of pain such as vocalisation.
Additional reasons why cats receive less analgesia post-operatively than dogs, may include the following:
According to the WSAVA pain management guidelines,4 the use of preventative/multimodal analgesia, along with careful tissue handling and adherence to good surgical principles is strongly recommended.
The guidelines additionally suggest that analgesia following castration or ovariohysterectomy/ovariectomy may be required for up to 3 days after surgery using non-steroidal anti-inflammatory drugs.
As part of this awareness campaign, ISFM, supported by Boehringer Ingelheim is running a free webinar on Wednesday 31st August at 8.00pm.
David Yates (Manchester RSPCA) and Jo Murrell (Reader in Veterinary Anaesthesia, Bristol University, UK) will be on hand to discuss, 'Neutering in practice: are your anaesthesia, analgesia and surgical protocols up to scratch?'
To register for the free webinar, go to: http://icatcare.org/learn/webinars and for further information about the campaign, visit: http://icatcare.org/campaigns/cats-deserve-pain-relief-too.
References
In his talk, 'Digital Veterinary Practice', Adam presents an exciting and compelling vision as to how technology will transform the profession and enable veterinary surgeons to offer better care to more patients.
His talk begins with an interesting look at how technological change has gathered pace in recent years, before considering some of the emerging technologies that could be applied to veterinary practice.
In particular, he talked about the so-called 'Internet of things': the way more and more 'things' other than computers are connected to the Internet.
There are now about 9bn 'things' connected to the internet, by 2020 there are expected to be 50bn. Adam predicted that more and more of them are going to be worn by animals: to measure reproductive health in farm animals; to track performance in equines; and to monitor behaviour and activity in companion animals.
Adam discussed how there is already a smart litter box which measures an animal’s habits, an oral pill camera that can take 360 degree internal photos, 3D printed drugs and digitised microscopy. By uniting these technologies with increasingly accurate virtual reality technology, he said, long-distance examinations could become a real possibility.
In relation to the role of the RCVS, Adam explored how the profession could be proactive in engaging with these technologies, such as by: using regulation as a mechanism to attract 'disruptors' to work alongside the profession; identifying areas of retraining and creating targeted learning opportunities; fostering an entrepreneurial mindset; creating an early-adopter network of practices to foster initial collaboration; and framing industry challenges as targeted problems whose solutions can be crowd-sourced.
The new pack includes a 60 minute video presented by leading veterinary behaviourist Jon Bowen BVetMed DipAS(CABC) MRCVS. The film covers hints and tips on the preventative measures that owners can put in place to help manage noise sensitivity and firework fears and also includes information on counter conditioning.
The packs, which are available from your CEVA territory manager, also include a range of waiting room materials including leaflets, leaflet holders, posters and wall displays, a PR toolkit to support individual veterinary practice PR campaigns, copy for websites, veterinary practice newsletters and suggested social media posts for Twitter and Facebook.
Claire Russell, Adaptil and Feliway product manager at Ceva Animal Health said: "The fireworks season can be a scary time for pets. Our new marketing pack will help veterinary practices remind their clients of the preventative measures they can put in place to reduce firework fears, including the use of Adaptil, proven to reduce the intensity of fear suffered as a result of loud noises."
For further information, contact your local Ceva territory manager or telephone 01494 781510.
Ceva says the new service is designed to help veterinary surgeons improve their consultations and client compliance with:
The site includes a considerable amount of video content, including talks by Cardio Academy's international experts, advice and demonstrations of blood pressure measurement, and training in radiography and echocardiography procedures and interpretation. The videos are supplemented with a number of reference publications to support and assist veterinary surgeons in everyday clinical and diagnostic procedures in the areas of cardiology, nephrology and hypertension. There are also interactive tools to help in the selection of treatments according to the stage of the disease or clinical objectives.
There are a number of communication tools which can be used during a consultation to support the veterinary surgeon's advice, manage client expectations and improve adherence to their recommendations. They can also be e-mailed to the pet owner so they can share the assessment with other family members.
An instant fitness test and an application for measuring resting respiratory rate allows owners to actively participate in the medical assessment of their pets and become more involved.
Finally, in order to maintain contact with pet owners between follow-up visits, the site offers several customisable clinical fact sheets and template newsletters containing content such as seasonal advice for a pet that has a heart condition.
For further information, contact your local Ceva account manager or visit www.vetintermed.ceva.com
The new bottle size will last approximately 100 days when treating an average sized cat of 4 kg.
Amy Scott, brand manager for Semintra said: "The new 100 ml bottle size will ensure that Semintra is even more convenient for owners, whilst facilitating long-term compliance that fits in well with recommended recheck intervals for CKD."
Cats with CKD have an overactive renin-angiotensin-aldosterone system (RAAS), which can lead to proteinuria and further progression of kidney disease. Semintra contains the active ingredient telmisartan – the only angiotensin receptor blocker (ARB) licensed for use in veterinary medicine. Boehringer says it provides targeted, long-lasting suppression of the RAAS1.
Semintra is a once daily oral liquid. Now available in both 30 ml and 100 ml bottle sizes, it has a six month shelf life after opening.
For further information on Semintra visit www.boehringer-academy.co.uk or contact your local Boehringer Ingelheim territory manager.
Reference
The statement, which can be downloaded here, is supported by a number of people and organisations in both the human and animal sector, including the BVA, Lyme Disease Action, the Blue Cross, Bristol, Nottingham and Surrey Universities.
The guidelines cover:
The statement was coordinated by MSD Animal Health and ESCCAP UK and Ireland in the run up to Tick Awareness Month, MSD's annual campaign coming up in September.
Amanda Melvin, Senior Product Manager, MSD Animal Health said: "The approval of this statement is very timely as we approach Tick Awareness Month. It is a major step forward for the industry by giving all the organisations involved a clear position on the subject. This will allow us to move forward together and tackle some of the issues related to ticks and tick borne diseases, including providing vets with clear practical guidelines for tick control.”
For further information about Tick Awareness Month, contact your MSD Animal Health representative.
The affected batches are: IsoFlo 250 ml 58006XN, 60003XN, 59005XN, 60006XN, 61001XN, 60016XN, 60017XN, 61018XN, 61015XN, 61016XN, 61017XN, 6062216, 6062225, 6062226, 6062217, 6063738 and Isothesia 250ml 6062335, 6063318.
Manufacturer Zoetis says there were a small number of reports of veterinary surgeons having difficulty in re-sealing the bottles after initial opening as the thread on the screw cap had not been fully formed. This defect does not impact the safety and efficacy of the product for animal use but the concern was related to potential evaporation from opened bottles which did not re-seal fully when closed.
Veterinary surgeons are asked to return any unopened bottles to the wholesaler and dispose of any opened bottles in the usual way. They will be fully reimbursed for the stock.
Zoetis says it has already addressed this packaging issue at the manufacturing site so that new batches of the product are unaffected.
Practices requiring further information on the matter should call Zoetis Technical Services on 0845 300 8034.
The WSAVA is calling on veterinary surgeons around the world and anyone with an interest in veterinary – and human – medicine to sign the petition to ensure access to ketamine in the face of lobbying by some countries, principally China, to have it put under international scheduling.
According to the WSAVA, proposals for international control stem from the misconception that ketamine is merely a 'recreational drug.' The WSAVA says this is inaccurate and devalues its huge contribution to human and animal medicine.
Dr Walt Ingwersen, WSAVA President Elect and Member of the WSAVA’s Global Pain Council, said: "In 2015, the WHO Expert Committee on Drug Dependence (ECDD) stated that the abuse of ketamine does not cause a global public health threat and that control would limit access for those using it as an anaesthetic. This view was confirmed at a meeting of the UN Commission on Narcotic Drugs in March 2016, helped by strong support view from the global medical and veterinary communities. However, China has repeated its view that ketamine should fall under international scheduling and we have no doubt that it will raise the issue again. This mean the risk to ketamine remains."
He added: "Ketamine is a safe anaesthetic which can be used without oxygen, ventilators, electricity and the support systems required for other products, making it the only anaesthetic suitable for both medical and veterinary use in lower and middle income countries. If developing countries were denied access to it, which would be the effect of international scheduling, the effects on veterinary medicine, human health and animal welfare would be devastating."
Dr Ganga de Silva, President of the Society of Companion Animal Practitioners of Sri Lanka, said: "Sri Lanka is a poor country with an underdeveloped veterinary profession. If ketamine was not available, in my opinion, all surgeries would have to cease as almost all of the veterinarians in the country rely on it for anaesthesia. The result would be suffering for animals and it would also seriously impact our ability to control rabies as we would not be able to carry out spay and neuter programs on stray dogs."
Dr Nancy Shaffran CVT, VTS(ECC), President of the International Veterinary Academy of Pain Management, said: “In addition to its use as an anaesthetic agent, ketamine is a critical medication used in the pain management in animals. The mechanism of action of ketamine (NMDA receptor antagonism) delivered as a Constant Rate Infusion has been well established to be effective in the prevention and correction of severe neuropathic pain and spinal cord wind-up. The loss of ketamine in veterinary practice would result in the needless suffering of many patients and we strongly oppose this action. We are very grateful for WSAVA’s efforts to keep ketamine available for our patients."
Dr Walt Ingwersen added: "Ketamine is also used in human medicine as it has a particular value for use 'in the field' - for instance, in treating trauma patients, those with traffic and sporting injuries or affected by natural disasters and conflict. Taking these factors together, it is clear that ketamine is an essential medicine and we are determined to ensure that it remains freely available. We are continuing to harness our global veterinary community to highlight the importance of ketamine because this is a battle our patients can’t afford us to lose. We ask all those agreeing with to sign our petition and help our collective voice grow."
The petition is here: http://chn.ge/1RFSou6.
The WSAVA’s Global Pain Council has produced a range of tools and resources, including an infographic, to support its ketamine campaign. They can be accessed here: http://www.wsava.org/educational/global-pain-council
Luke will receive his award at the 2016 WSAVA World Congress, which takes place from 27-30 September in Cartagena, Colombia, where he will also give a lecture on his work, entitled ‘One Mission’.
The WSAVA Global One Health Award is presented by the WSAVA’s One Health Committee (OHC) to an individual who has promoted an aspect of One Health relevant to small companion animals.
Luke graduated from Bristol University in 1999 and is based in his New Forest surgery, Pilgrims Veterinary Practice. In 2003, he set up Worldwide Veterinary Service (WVS), a charity providing veterinary aid around the world, followed, in 2013, by sister charity, Mission Rabies, which is leading the battle against canine rabies and works closely with the WSAVA’s charitable Foundation. Luke is CEO of both organisations and has raised more than four million pounds to support the charities’ projects around the world. He lectures internationally on animal welfare and veterinary subjects and, in 2014, was asked by the World Health Organisation (WHO) to sit on an expert panel for the International Control of Neglected Zoonotic Diseases based on his rabies work globally.
Professor Michael Day, Chair of the WSAVA OHC, said: "The current most significant example of the importance of a One Health approach to disease control relates to the global fight against canine rabies - a disease that continues to cause an estimated minimum 59,000 human deaths each year. Luke is a world leader in this global fight. Mission Rabies runs mass vaccination campaigns and provides public education in Asia and Africa, having now vaccinated almost 400,000 dogs, spoken to over 500,000 schoolchildren and successfully controlled rabies in selected target areas.
"The Mission Rabies programme is grounded in solid evidence-based science, with the field data collected having now generated the first high-class scientific manuscripts. Luke is a truly inspirational and charismatic leader who believes in simply getting on with the job at hand. The achievements of Mission Rabies and its sister charity, Worldwide Veterinary Service, readily show that even the greatest global health challenges are not insurmountable."
Luke said: "It’s a huge honour to receive this Award and I accept it on behalf of an amazing team - without whom - the projects would be impossible. It’s an utter privilege to be a part of the veterinary profession and fighting diseases like rabies is an incredible opportunity to champion both animals and people – something we can all identify with. I’m totally indebted to WSAVA and the international veterinary community, whose support has been overwhelming, and it is only with this unity, that we can keep driving forward – and winning."
The trial starts on Monday 11 July and will continue for three months to allow the College to determine levels of demand for such a service and, therefore, whether it should be made permanent.
Eleanor Ferguson, RCVS Acting Registrar, said: "This was a potential service identified in our Strategic Plan as a way of allowing veterinary professionals to have informal, confidential, discussions with members of the Professional Conduct Department about potential fitness to practise issues, short of formally raising a concern.
"Although any discussions via the new reporting line or email address will be confidential, if a veterinary surgeon or a veterinary nurse subsequently wishes to raise a formal concern about another veterinary professional, then they generally will need to identify both themselves and the individual in order to take it through our investigation process.
"We have developed a bespoke concerns form for members of the professions who do want to raise concerns about other professionals."
Veterinary surgeons and veterinary nurses who wish to contact a member of the RCVS Professional Conduct Department in confidence can do so by calling 07599 958 294 between 9am and 5pm, or by emailing reporting@rcvs.org.uk.
The bespoke concerns from for members of the profession can be downloaded from www.rcvs.org.uk/concerns.
Now, when you advertise a job on VetSurgeon.org, the system can send a message to all your employees (and any contacts in the profession) asking them to pass it on if they know anyone suitable, and to share the advertisement on their other social networks, such as Facebook.
As a further option, practices can also now offer a cash reward for a successful introduction leading to the post being filled. In that case, the message sent to employees and contacts lets them know that there’s a reward for their help.
VetSurgeon.org Editor Arlo Guthrie said: "Since we relaunched VetSurgeon Jobs, I’ve noticed a correlation between the number of times that job advertisements are shared by email or on Facebook, and the success that practices have in filling the vacancy.
"Of course, there is nothing to stop you emailing staff and contacts yourself, or offering a reward. But I suspect many don’t, and my hope is that this new feature will really help focus the mind, streamline the process and ultimately help you find the person who'll fit in with your team."
"Share & Reward is another feature exclusively available on VetSurgeon Jobs, alongside the VetSurgeon Locums Map and Find Our Jobs on VetSurgeon (a badge for your website that links to just your jobs).
"There's more on the way!"
The service will be available to veterinary practices that use more than £250/€300 of Royal Canin urinary diets per year.
The company has enlisted the support of an independent laboratory to carry out an infrared spectroscopy analysis of the stones, in order to make a quantitative and qualitative assessment of their composition. Royal Canin says that by appreciating the mineral-type in all layers, the best dietary recommendation can be made.
Lee Danks, Royal Canin’s Veterinary Scientific Support Manager, said: "Managing cat and dog urolithiasis can be challenging. This valuable service will improve practices’ diagnostic capacity, enabling a better understanding of a patient’s condition and a much more individualised approach to treatment and long-term prevention."
Royal Canin says there are many complex and interacting contributors to urinary stone formation1. Dietary modifications can influence urine pH, the concentration of minerals within the urine and most critically, urine turn-over through the bladder2. The many interactions between promotors and inhibitors of urolithiasis highlight just how critical a tailored nutritional approach can be to the long-term health of urinary patients.
The Veterinary Medicines Directorate (VMD) has given VetSurgeon the data on which these stories were based.
In the 3.5 years since the vaccine was authorised, the incidence of suspected adverse animal reactions has been 0.064%. In other words, for every 10,000 doses sold, the VMD has received reports of 6 suspected adverse reactions. This incidence is considered 'rare', according to the following convention:
The VMD reports that amongst the 40+ authorised dog vaccines in the UK, the incidence of suspected adverse reactions ranges from 0.002% (classified 'very rare') to 0.3% (classified 'uncommon')
However, the VMD is at pains to stress that suspected adverse reaction reports should not be used to compare the relative safety of products. They are, after all, only 'suspected' adverse reactions. The reliability of suspected adverse reaction reports is further complicated by the fact that vaccination against leptospirosis rarely occurs in isolation, making it very difficult to interpret which adverse reactions are attributable to Leptospira vaccines.
Many vaccines providing protection against leptospirosis also contain components for prevention of other diseases, such as distemper, parainfluenza and parvovirus. In addition, many dogs are vaccinated concurrently against other diseases, such as kennel cough and/or rabies, and other products (e.g. flea and worm treatments) may be administered at the same visit. Therefore the clinical signs observed may be related to any of the products used or they may be unrelated.
The VMD says the majority of the most commonly reported suspected adverse reactions to Nobivac L4 are linked to allergic type reactions which are well-recognised potential side effects of any vaccine, and are presented on the product literature.
As to the newspaper claim that: "The World Small Animal Veterinary Association (WSAVA) is urging owners not to use Nobivac L4 vaccine on puppies under 12 weeks old.", the WSAVA denied this in the strongest possible terms, saying: "This statement is blatantly untrue. The WSAVA would never ‘urge owners’ and would never make recommendations about individual named commercial products."
In a statement issued in response to the newspaper story, MSD said: "Nothing is more important to MSD Animal Health than the safety and efficacy of our products, and the health and well-being of animals.
"Nobivac L4 was launched in 2013 across Europe to prevent dogs from contracting Leptospirosis which is a serious zoonotic disease. It is one of the most widely used vaccines for dogs with several million doses being used annually to successfully prevent infection in dogs."
"As a responsible animal health company, we take every adverse reaction report seriously and investigate thoroughly. Whenever possible, we work with the pet owner and attending veterinary surgeon to assemble as much clinical information as we can to help determine the cause of a pet’s health issue, and whether or not the product may have been involved .
"We report findings to governing regulatory agencies around the world (based on a country’s respective laws and policies), so that they can make a fully informed, scientific assessment about the safety of the product. We do this so that accurate safety and efficacy information is available for veterinary surgeons prescribing our products."
In a parting shot, the WSAVA said: "The WSAVA guidelines are publicly available on-line and this journalist has clearly not undertaken adequate research before publishing this article."
See: www.wsava.org/educational/vaccination-guidelines-group
Currently used by more than 200 practices and 50 universities around the world, the Equinosis Q is a diagnostic tool that can further aid the subjective lameness evaluation on all types of horses and ponies examined in the field or in hospital settings.
Christina Frigast, MRCVS, Eickemeyer Product Development Manager said: "The inertial sensors sample 20x faster than the human eye making the Equinosis Q a valuable tool to the veterinarian in the evaluation of subtle and multiple limb lameness.
"It does not interfere with the routine lameness examination as trot up on straight line, lunging and ridden evaluations can be performed on both hard and soft surfaces.
"Data is wirelessly streamed to a tablet PC and compiled into a reader-friendly report displaying the timing and severity of lameness. The effectiveness of diagnostic blocks can also be assessed with the Equinosis Q, providing the veterinarian with a percentage of improvement. In addition, comparison reports can be used to monitor rehabilitation progress."
Contact Eickemeyer to book a free demo, or for further information, visit: https://www.eickemeyer.co.uk/Diagnostics-and-Education/Anatomy-Models/Lameness-Locator-vet.html?listtype=search&searchparam=lameness
watch?v=MS6UXQSq6q0
The kit contains a guide to effective ear cleaning, an illustrated step-by-step instruction guide on how to administer the Canaural, and a diary and consultation pack so owners can engage with the diagnosis and treatment of their pet’s ear infection.
The Healthy Ears Combi Kit comes in a resealable wipe-clean bag and is available free of charge from veterinary wholesalers.
Dechra Brand Manager Claire Morgan said: "The new kit will give owners more confidence in the important role that they play in their pet’s ear health and encourage them to engage in the treatment plan, thereby supporting veterinary professionals in the cycle of care.
"As well as serving as practical storage for the products, it acts as a reminder to dispense CleanAural as well as Canaural, as the self-cleaning mechanism of the animal’s ears is often compromised by infection.
She added: "CleanAural does not compromise the antimicrobial activity of Canaural1 so they are perfect partners for maintaining healthy ears."
Free Healthy Ears Combi Kit can be ordered via your veterinary wholesaler.
Drawing attention to the symptoms of allergic skin disease that owners should look out for during the warmer months, the leaflet, poster and notice board materials discuss some of the substances that dogs can be allergic to, how to manage skin allergies and what to look for in an itch prevention plan.
The materials have been produced to support Apoquel, the oral therapy for the treatment of canine pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis. They feature two dogs – Eric and Daisy – whose lives have been changed by the product.
For more information, contact your Zoetis account manager.
Bovalto Respi vaccines contain a newly developed combination of viral and bacterial antigens. Merial says the recent vaccine isolates effectively target current European-circulating Bovine Respiratory Disease (BRD) strains. Bovalto antigens are also proven by challenge, including at six months post-vaccination to confirm long-lasting protection.
Henry Berger, Global Head of the Ruminant and Equine Business Unit at Merial, said: "Merial is committed to understanding the needs of cattle producers and delivering unique, targeted solutions. Merial is dedicated to expanding its portfolio of parasiticides, vaccines and other disease prevention solutions, with high-value products like Bovalto Respi, to improve productivity, and keep herds healthy."
Merial highlights that BRD is complex to manage and each year affects an estimated 1.9 million animals1, costing the UK cattle industry around £60 million2. In Ireland BRD is responsible for 30% of deaths in stock under one-year old3.
At a Merial symposium at WBC 2016, Prof. Sandro Cavirani, Director of the Department of Animal Health at the University of Parma, Italy highlighted the importance of successful BRD control programmes in calves to optimise herd immunity and productivity, including early, repeated and targeted BRD vaccination.
Bovalto Respi 3 contains strains of Parainfluenza Virus 3, Bovine Respiratory Syncytial Virus, and Mannheimia haemolytica serotype A1. The combination in Bovalto Respi 4 combines the three pathogens in Bovalto Respi 3, with the added strain of Bovine Viral Diarrhoea Virus (BVDV).
The 3D dental model, which was produced with the help of veterinary dentist John Robinson, demonstrates the recommended method for sectioning and extracting teeth in cats and dogs.
An accurate representation of the animal’s mouth, the teeth are pre-sectioned, indicating how tooth crowns should be divided and where to cut the crown to achieve single root pieces.
Royal Canin's Veterinary Marketing Manager, Marianne Lomberg, said: "We are delighted to offer this new learning tool. These high quality and accurate models will be a valuable addition to the education resources available to veterinary schools and professionals – ultimately helping contribute to a higher standard of dental care available to cats and dogs."
Orders of £300 will receive one free model, orders of £500 will receive two free models.
For more information, contact your Royal Canin Veterinary Business Manager or visit www.vetportal.royalcanin.co.uk.
Amanda Melvin, Senior Product Manager, said: "We’re very excited about this approval as it will allow us to build on the success of our Bravecto chewable tablets for dogs and provide veterinarians and cat owners with another tool in the fight against ticks and fleas. Being able to offer a full 12 week protection means convenience for cat owners and improved compliance rates for veterinarians, so everyone benefits."
Bravecto is applied topically using the new "Twist’n’Use" pipette design which means the cap doesn’t need to be removed.
Full product details are described in the summary of product characteristics (SPC).
For more information, contact your MSD Animal Health representative.
It is hoped the findings, which were unveiled at the House of Commons yesterday, will enable the welfare priorities of the UK’s 800,000 horses to be addressed.
This is the first time welfare organisations, breeders, the equine industry and the veterinary profession have come together to agree on a strategy to best improve the welfare of horses in the UK.
The equine welfare study found the welfare needs of many horses are not currently being met and the report has highlighted four welfare priorities.
Dr Siobhan Mullan, Research Fellow in Animal Welfare Science, Ethics and Law at the University of Bristol and one of the report’s authors, said: "Bringing together the views of people associated with horses in England and Wales has provided an overview of horse welfare, from the day-to-day concerns of equine caregivers to identifying four priority challenges to equine welfare.
"This research has also identified how equine welfare can be improved, by addressing both the priority challenges, and a wider set of industry and horse-based needs."
Roly Owers, World Horse Welfare Chief Executive, added: "This research report provides a vital insight to the UK’s equine sector, mapping out the welfare landscape from a wide range of sector experts and stakeholders.
"In order for World Horse Welfare and others to most effectively address the welfare challenges facing UK equines, we need to better understand today’s welfare priorities and this research will provide a valuable guide to help in driving the focus of our educational initiatives and resources over the next few years.”
The priority welfare challenges and solutions outlined in the report are:
Unresolved stress/pain behaviourProblems associated with unresolved stress/pain behaviour affect large numbers of horses, often for long durations with variable severity of suffering caused to individual horses.
More academic research is needed to fully understand the links between behaviour, stress and pain, and objective measures of stress and pain in horses should be developed. Vets, riding instructors, the Pony Club, riding clubs and the equine press have a role in educating horse caregivers about signs of stress and pain and the appropriate responses. Academics and experts also have a role in tackling this issue through evaluating the effectiveness of intervention programmes.
Inappropriate nutritionOverfeeding and obesity are the main welfare problems associated with nutrition and affect large numbers of horses, often for a long time with varying severity of suffering.
Vets have a key role in tackling the problems associated with inappropriate nutrition. A consistent approach by all vets is needed, to prevent horse owners choosing vets that don’t challenge owners about their horses’ nutrition. Feed companies can also play an important role in tackling this issue, although many feed companies already offer appropriate nutrition for a range of horses and exercise situations. Better owner education, based on existing good research, would ensure the right nutritional choices are made for individual horses.
Inappropriate stabling /turnoutWelfare of horses is compromised when the amount of time spent at pasture/stabled does not meet their individual needs, when they are kept in social isolation or when they are exposed to unsuitable grazing conditions. Welfare problems associated with incorrect stabling/turnout affect large numbers of horses for a long time with variable levels of suffering.
Although all horse owners make choices relating to the amount and type of stabling and turnout experienced by their horses, livery yard owners could play a role in addressing this issue. For example, by encouraging different approaches to management, including group housing and the use of all-weather turnout facilities. Strengthening legislation is another possible way for improvement but a ‘one size fits all’ approach would be inappropriate. For example, for some horses, turn out to pasture may not always be suitable.
Delayed deathHorses may be kept alive inappropriately resulting in firstly, prolonging welfare problems, such as continued suffering of a horse in pain. This affects relatively large numbers of horses, for short periods of time with the severity of suffering often being severe. Secondly, an increased risk of suffering, for example where horses are unwanted by their owners, become low value and subsequently aren’t cared for well.
One way for improvement could be by putting pressure on the EU to make changes to the passport regulations. In particular, legislation changes that would enable horses who had received medications, including Phenylbutazone, to be slaughtered to enter the human food chain after a six month withdrawal period. In addition, challenging negative attitudes of horse owners towards timely euthanasia is important.
The research, undertaken over a four year period, was to understand the welfare status of horses in England and Wales, identify priority welfare issues and explore horse owner and industry experts’ perceptions of these issues.
Stakeholders from across the equine industry contributed to the research: from vets to farriers and welfare charities to governing body representatives, participants represented a wide-reaching cross section of horse care roles and responsibilities.
During the 60 days before to 30 days after calving, dairy cows experience a dip in their natural immunity, leaving them especially vulnerable to important diseases such as mastitis2, metritis3 and retained placenta.4 With serious cost consequences and implications for cow welfare and productivity, this makes the transition period one of the most challenging yet vital periods for vets to manage with dairy clients.
Imrestor (pegbovigrastim injection) is a pegylated form of the naturally occurring protein cytokine, bovine Granulocyte Colony Stimulating Factor (bG-CSF). Elanco says it helps restore the cow’s natural defences by increasing the number and restoring the function of neutrophils, the primary type of white blood cell that recognizes and kills harmful bacteria.
Fiona Anderson, Technical Vet at Elanco, said: "It’s no secret that a successful transition period is vital for maximising productivity in the next lactation, yet we are still ‘firefighting’ common transition diseases like mastitis rather than focusing on their true cause."
"Vets are under increasing pressure to adopt a more proactive approach, not least to reduce the use of antibiotics in livestock but with few credible alternatives. This can be challenging in dairy herds, particularly around calving when cows are susceptible to multiple disease challenges while their defences are low. Imrestor helps to restore a cow’s own natural immunity and strengthen her ability to defend against infection by a range of mastitis pathogens – thus helping to protect the cow against mastitis when she needs it most."
Available in pre-filled, single-dose syringes, Imrestor is administered with two injections – one seven days prior to the anticipated date of calving and the other within 24 hours after calving – with neither injection requiring a withdrawal period.
Kingsley Baxendale, Ruminant Marketing Manager at Elanco Animal Health said: "It can be extremely frustrating for vets to see their dairy farmers struggling with the stress and hassle of dealing with increased numbers of sick cows during calving; they have enough to deal with at the moment. We’re delighted that Imrestor can provide vets with a tool to help decrease the negative consequences associated with immune-related diseases like mastitis and maximise their herds’ lactation potential."
As part of the launch of Imrestor, Elanco also announced its new 'Pledge To Protect' initiative to encourage vets and farmers to make a pledge symbolising their commitment to address immune suppression in their dairy cows.
The number of pledges will be tracked using a life-sized 2D cow model, pictured above. For each pledge, which can be made online or at events, Elanco will make a £5 donation to The Royal Agricultural Benevolent Institution (R.A.B.I), which supports farmers in difficulty. As a thank you for showing support, all pledgers will automatically be entered into a weekly prize draw.
To find out more about using Imrestor and how you can make your pledge, visit www.vital90days.co.uk.
The new 10ml (10-dose) and 100ml (100-dose) packs of Ingelvac PRRS EU are available now, and will complement the existing 50ml (50-dose) packs.
Callum Blair MRCVS, Swine Brand Manager at Boehringer Ingelheim, said: "Nobody likes to end up with part used bottles of any vaccine that then have to be discarded. The addition of Ingelvac PRRS EU 10-dose and 100-dose packs will provide choice for different sized units and help reduce wasted doses."
For more information, visit www.prrs.com.
VetSurgeon Editor Arlo Guthrie said: “The original setup, which reorders a list of available positions by distance from a location, works very well when you know where you want to work.
"The new VetSurgeon Jobs Map, on the other hand, is ideal for when you’re not sure where exactly you want to work, and just want to know what’s out there.
"We’ve also added a 'World Jobs Map' so that there’s a quick and easy way to see any jobs outside the UK, such as those currently advertised in Bahrain, South Africa and Ireland."
The VetSurgeon Jobs Map is the latest in a string of new features added since a small charge was introduced for advertising jobs in May, including Find our jobs on VetSurgeon, Share & Reward and the VetSurgeon Locums Map. The same features have also been added over on VetNurse Jobs, too.
Arlo said: "Now that we charge for advertising on VetSurgeon Jobs, I’m interested in only one thing, which is offering both job seekers and recruiters the best service available anywhere."